Effects of Vital Shower on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorCharite University, Berlin, Germany

About this trial

The aim of this exploratory randomized controlled clinical study is to evaluate the health-promoting effects of Kneipp hydrotherapy, in the form of the Vital Shower in a four-week daily application.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Female and male patients between 18 and 70 years of age

Disqualifiers

Bad general condition

Serious acute or chronic comorbidity

Pregnancy and breast feeding period/ in the next 6 months

Participation in a clinical trial within the last 3 months before enrollment

Trial design

Design model

Parallel

Treatments tested in this trial

  • Hansgrohe prototype/shower head

    Device

    Start of the shower with warm comfort temperature and usual body cleansing. Then the Vital shower is carried out for a total of 3-5 minutes, followed optionally by another warm shower with 30 seconds or direct transition to a classic cold shower for 30- 60 seconds

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Vital showerActive comparator 1 intervention
Group B: Regular showerNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Immunological laboratory

T-Cells (CD3), B-Cells (CD19), Natural Killer Cells (CD16), T-helper cells (CD4), cytotoxic T-cells (CD8), CD4/CD8 ratio, interleukin 4, interferon gamma

Time frame
Change from Baseline and after 4 weeks
2

Blood pressure at rest (systolic and diastolic)

Time frame
Change from Baseline and after 4 weeks
3

Hospital Anxiety and Depression Scale (HADS-D)

Change

Time frame
Change from HADS-D Baseline, after 4 weeks and 12 weeks
4

Self-Efficacy Scale (ASKU)

Change

Time frame
Change from ASKU Baseline, after 4 weeks and 12 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.